HIV and Hepatitis Policy Institute

Analysis

HIV and Hepatitis Policy Institute is a registered charity in United States, based in Washington, DC. It received its IRS tax-exemption ruling in February 2021, 5 years ago. Its declared purposes cover health care, which this site groups under health and saving lives. The IRS classifies it as a publicly supported organisation (donations from the general public) under section 501(c)(3), and contributions to it are listed as tax-deductible.

In the financial year ending December 2023, HIV and Hepatitis Policy Institute reported income of $1.3m and spending of $1.0m, leaving 21% of income unspent that year. Across the 4 years on record, from December 2020 to December 2023, income grew from $722k to $1.3m (+82%), an average of +22% a year. The sharpest change came in the year to December 2021, when income rose by 50%. Over the whole period it spent 75% of the income it received.

Among 40,470 United States charities whose main cause is health and saving lives and that reported income, HIV and Hepatitis Policy Institute sits at the 67th percentile: it is larger than about 67% of them. Against every charity in United States with reported income it ranks in the 82nd percentile, and in the 59th percentile within DC. Charities of a similar size with the same main cause include Boyertown Lions Community Ambulance Service Inc ($1.3m), Davids House Inc ($1.3m) and Regenesis ($1.3m).

On its Form 990 for the period ending December 2023, revenue came from contributions and grants 99% of the total. Compensation of current officers, directors and key employees was $257k (25% of expenses). Other salaries and wages came to $206k. At year end it held assets of $1.1m against liabilities of $0, net assets of $1.1m. It reported 3 employees.